Enthusiasm for fenestrated stent grafts, which are meant to treat abdominal aortic aneurysms (AAA) that branch off in a manner that cannot be addressed by standard endovascular grafts was evident at last month’s Veith Symposium in New York. But the specialized devices, just recently made available in the U.S., shared attention at the meeting with a set of less costly and time-intensive alternative procedures referred to as CHIMPS.
The first fenestrated stent graft launched in the U.S. in April when Cook Group Inc.’s Zenith Fenestrated AAA graft gained PMA supplement approval from FDA. (See Also see "
